Cardiogenic shock in a patient being treated with atezolizumab for metastatic non-small cell lung cancer

被引：8
作者：
Liu, Ellen [1 ]
Guha, Avirup [2 ]
Bertino, Erin [3 ]
Franco, Veronica [2 ]
机构：
[1] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA
[2] Ohio State Univ, Dept Internal Med, Div Cardiol, Columbus, OH 43210 USA
[3] Ohio State Univ, Dept Internal Med, Div Oncol, Columbus, OH 43210 USA
来源：
LUNG CANCER | 2017年 / 114卷
关键词：
RANDOMIZED CONTROLLED-TRIAL; OPEN-LABEL; MULTICENTER; MYOCARDITIS; DOCETAXEL;
D O I：
10.1016/j.lungcan.2017.07.028
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：106 / 107
页数：2
相关论文
共 50 条
  • [21] Immunotherapy for the First-Line Treatment of Patients with Metastatic Non-Small Cell Lung Cancer
    Martinez, Pablo
    Peters, Solange
    Stammers, Timothy
    Soria, Jean-Charles
    CLINICAL CANCER RESEARCH, 2019, 25 (09) : 2691 - 2698
  • [22] Toxic Epidermal Necrolysis Related to Cisplatin and Pemetrexed for Metastatic Non-Small Cell Lung Cancer
    Scheinpflug, Katrin
    Menzel, Carina
    Koch, Antje
    Kahl, Christoph
    Achenbach, Hans J.
    ONKOLOGIE, 2012, 35 (10): : 600 - 603
  • [23] Immunotherapy in Advanced Non-Small Cell Lung Cancer
    Huang, Joy
    Reckamp, Karen L.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 41 (03) : 400 - 408
  • [24] Afatinib for the treatment of metastatic non-small cell lung cancer
    Joshi, Monika
    Rizvi, Syed M.
    Belani, Chandra P.
    CANCER MANAGEMENT AND RESEARCH, 2015, 7 : 75 - 82
  • [25] Pembrolizumab for the treatment of non-small cell lung cancer
    Muller, Mirte
    Schouten, Robert D.
    De Gooijer, Cornedine J.
    Baas, Paul
    EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (05) : 399 - 409
  • [26] Potential synergistic effects of cranial radiotherapy and atezolizumab in non-small cell lung cancer: an analysis of individual patient data from seven prospective trials
    Guo, Tiantian
    Zhou, Yue
    Liang, Fei
    Wang, Zezho
    Bourbonne, Vincent
    Kaesmann, Lukas
    Sundahl, Nora
    Jing-Ching, Abraham
    Ni, Jianjia
    Zhu, Zhengfe
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (01) : 126 - 145
  • [27] Atezolizumab in aCoHort of pretreated, advanced, non-small cell lung cancer patients with rare HistologiCal SubtypEs (CHANCE trial)
    Gelsomino, Francesco
    Lamberti, Giuseppe
    Tiseo, Marcello
    Rocco, Danilo
    Pasello, Giulia
    Cecere, Fabiana Letizia
    Chella, Antonio
    Grilli, Giada
    Mandruzzato, Marcella
    Tognetto, Michele
    Garassino, Marina Chiara
    Macerelli, Marianna
    Novello, Silvia
    Roila, Fausto
    Colantonio, Ida
    Grossi, Francesco
    Fiorentino, Michelangelo
    Ardizzoni, Andrea
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [28] Significance of inflammatory indexes in atezolizumab monotherapy outcomes in previously treated non-small-cell lung cancer patients
    Katayama, Yuki
    Yamada, Tadaaki
    Chihara, Yusuke
    Tanaka, Satomi
    Tanimura, Keiko
    Okura, Naoko
    Hirose, Kazuki
    Uda, Sayaka
    Shiotsu, Shinsuke
    Hirai, Soichi
    Hiranuma, Osamu
    Harada, Taishi
    Shimamoto, Takayuki
    Iwasaku, Masahiro
    Kaneko, Yoshiko
    Uchino, Junji
    Takeda, Takayuki
    Takayama, Koichi
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [29] Atezolizumab for first-line treatment of metastatic nonsquamous non-small cell lung cancer: what makes the difference?
    Bersanelli, Melissa
    Petrelli, Fausto
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S3241 - S3243
  • [30] A Model of Overall Survival Predicts Treatment Outcomes with Atezolizumab versus Chemotherapy in Non-Small Cell Lung Cancer Based on Early Tumor Kinetics
    Claret, Laurent
    Jin, Jin Y.
    Ferte, Charles
    Winter, Helen
    Girish, Sandhya
    Stroh, Mark
    He, Pei
    Ballinger, Marcus
    Sandler, Alan
    Joshi, Amita
    Rittmeyer, Achim
    Gandara, David
    Soria, Jean-Charles
    Bruno, Rene
    CLINICAL CANCER RESEARCH, 2018, 24 (14) : 3292 - 3298
12345